2002
DOI: 10.4049/jimmunol.168.1.443
|View full text |Cite
|
Sign up to set email alerts
|

Pronounced Eosinophilic Lung Inflammation and Th2 Cytokine Release in Human Lipocalin-Type Prostaglandin D Synthase Transgenic Mice

Abstract: PGD2 is a major lipid mediator released from mast cells, but little is known about its role in the development of allergic reactions. We used transgenic (TG) mice overexpressing human lipocalin-type PGD synthase to examine the effect of overproduction of PGD2 in an OVA-induced murine asthma model. The sensitization of wild-type (WT) and TG mice was similar as judged by the content of OVA-specific IgE. After OVA challenge, PGD2, but not PGE2, substantially increased in the lungs of WT and TG mice with greater P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
172
1
2

Year Published

2003
2003
2015
2015

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 211 publications
(181 citation statements)
references
References 57 publications
5
172
1
2
Order By: Relevance
“…Besides chemotaxis, we have shown that activation of CRTH2 also causes eosinophil respiratory burst and the release of eosinophils from the bone marrow [10]. In vivo, PGD 2 can induce pulmonary eosinophilia [11], and a significant contribution of PGD 2 to the late phase allergic reaction is suggested by enhanced eosinophilic lung inflammation and cytokine release in transgenic mice overexpressing PGD 2 synthase [12]. However, eosinophils also express the DP receptor [13], which is a second receptor for PGD 2 , and DPdeficient mice have reduced pulmonary responses to allergen [14].…”
Section: Introductionmentioning
confidence: 92%
“…Besides chemotaxis, we have shown that activation of CRTH2 also causes eosinophil respiratory burst and the release of eosinophils from the bone marrow [10]. In vivo, PGD 2 can induce pulmonary eosinophilia [11], and a significant contribution of PGD 2 to the late phase allergic reaction is suggested by enhanced eosinophilic lung inflammation and cytokine release in transgenic mice overexpressing PGD 2 synthase [12]. However, eosinophils also express the DP receptor [13], which is a second receptor for PGD 2 , and DPdeficient mice have reduced pulmonary responses to allergen [14].…”
Section: Introductionmentioning
confidence: 92%
“…In addition, PGD 2 also possesses effector functions during inflammation. For instance, the production of PGD 2 by allergen-activated mast cells and possibly by Agchallenged Th2 lymphocytes is involved in allergic reactions that develop in the lungs [3][4][5]. On the other hand, PGD 2 also appears to mediate regulatory functions during inflammation for example by down-regulating carrageenin-induced pleurisy and colitis in rats [6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…PGD 2 is a major mast cell mediator released during the allergic response (5), but its ability to induce chemotaxis of eosinophils, basophils, and Th2-type T cells via a novel receptor, CRTH2, has only recently been realized (6,7). A significant contribution of PGD 2 to the late phase allergic reaction is suggested by enhanced eosinophilic lung inflammation and cytokine release in transgenic mice overexpressing PGD 2 synthase (8) and amelioration of lung eosinophilia and airway hyper-reactivity in mice deficient of the classical PGD 2 receptor, DP (9).…”
Section: E Osinophils Are Important Effector Cells In Allergic Diseasesmentioning
confidence: 99%